MEDIPHARM LABS CORP (LABS.CA) Stock Analyst Earnings Estimates
TSX:LABS - Toronto Stock Exchange - CA58504D1006 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.1M 1.84% | 33.062M 49.60% | 41.961M 26.92% | 47.199M 12.48% | 54.645M 15.78% | |
| EBITDA YoY % growth | -26.33M 42.09% | -17.098M 35.06% | -9.039M 47.13% | -1.76M 80.53% | 3.976M 325.97% | |
| EBIT YoY % growth | -29.2M 42.86% | -19.614M 32.83% | -11.639M 40.66% | -1.716M 85.26% | -2.251M -31.21% | |
| Operating Margin | -132.13% | -59.32% | -27.74% | -3.63% | -4.12% | |
| EPS YoY % growth | -0.11 52.17% | -0.04 63.64% | -0.04 | -0.01 74.50% | 0.00 100.00% |
All data in CAD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.00 79.60% | 0.00 89.80% | 0.00 89.80% |
| Revenue Q2Q % growth | 11.226M 8.46% | 12.093M 23.42% | 13.248M 10.01% |
| EBITDA Q2Q % growth | 218.28K 116.62% | 451.86K 151.23% | 294.78K -25.93% |
| EBIT Q2Q % growth | -660.96K 76.68% | -427.38K 85.37% | -395.76K 82.03% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.00 90.00% | 0.00 | 0.00 | 75.49% |
| Q4 2024 Q2Q % growth | -0.01 | 0.00 | -0.01 | % |
| Q3 2024 Q2Q % growth | -0.01 | 0.00 | -0.01 | % |
| Q2 2024 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q1 2024 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.01 66.67% | -0.01 | 0.00 | -96.08% |
| Q2 2023 Q2Q % growth | -0.01 66.67% | -0.02 | 0.01 | 34.64% |
| Q1 2023 Q2Q % growth | -0.01 66.67% | -0.02 | 0.01 | 34.64% |
| Q4 2022 Q2Q % growth | -0.02 75.00% | -0.02 | 0.00 | -30.72% |
| Q3 2022 Q2Q % growth | -0.03 | -0.02 | -0.01 | -47.06% |
| Q2 2022 Q2Q % growth | -0.03 40.00% | -0.02 | -0.01 | -47.06% |
| Q1 2022 Q2Q % growth | -0.03 57.14% | -0.02 | -0.01 | -47.06% |
| Q4 2021 Q2Q % growth | -0.08 61.90% | -0.02 | -0.06 | -292.16% |
| Q3 2021 Q2Q % growth | -0.03 72.73% | -0.02 | -0.01 | -47.06% |
| Q2 2021 Q2Q % growth | -0.05 -400.00% | -0.03 | -0.02 | -63.40% |
| Q1 2021 Q2Q % growth | -0.07 -133.33% | -0.03 | -0.04 | -128.76% |
| Q4 2020 Q2Q % growth | -0.21 -950.00% | -0.03 | -0.18 | -586.27% |
| Q3 2020 Q2Q % growth | -0.11 -650.00% | -0.03 | -0.08 | -259.48% |
| Q2 2020 Q2Q % growth | -0.01 -200.00% | -0.04 | 0.03 | 75.49% |
| Q1 2020 Q2Q % growth | -0.03 -200.00% | -0.01 | -0.02 | -194.12% |
| Q4 2019 Q2Q % growth | -0.02 | 0.01 | -0.03 | -296.08% |
| Q3 2019 Q2Q % growth | 0.02 | 0.03 | -0.01 | -34.64% |
| Q2 2019 Q2Q % growth | 0.01 | 0.01 | 0.00 | 96.08% |
| Q1 2019 Q2Q % growth | -0.01 | 0.01 | -0.02 | -296.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 10.806M 10.59% | 10.753M | 53K | 0.49% |
| Q4 2024 Q2Q % growth | 12.042M 31.88% | 11.116M | 926K | 8.33% |
| Q3 2024 Q2Q % growth | 9.798M 15.20% | 12.486M | -2.688M | -21.53% |
| Q2 2024 Q2Q % growth | 10.35M 8.00% | 10.466M | -116K | -1.11% |
| Q1 2024 Q2Q % growth | 9.771M 67.23% | 9.63M | 141K | 1.46% |
| Q4 2023 Q2Q % growth | 9.131M 62.47% | 8.838M | 293K | 3.32% |
| Q3 2023 Q2Q % growth | 8.505M 17.15% | 10.574M | -2.069M | -19.57% |
| Q2 2023 Q2Q % growth | 9.583M 119.79% | 13.766M | -4.183M | -30.39% |
| Q1 2023 Q2Q % growth | 5.843M 19.73% | 6.324M | -481K | -7.61% |
| Q4 2022 Q2Q % growth | 5.62M -2.09% | 5.949M | -329K | -5.53% |
| Q3 2022 Q2Q % growth | 7.26M 34.44% | 5.03M | 2.23M | 44.33% |
| Q2 2022 Q2Q % growth | 4.36M -14.00% | 5.512M | -1.152M | -20.90% |
| Q1 2022 Q2Q % growth | 4.88M -11.27% | 6.139M | -1.259M | -20.51% |
| Q4 2021 Q2Q % growth | 5.74M -5.28% | 6.042M | -302K | -5.00% |
| Q3 2021 Q2Q % growth | 5.4M 9.09% | 6.355M | -955K | -15.03% |
| Q2 2021 Q2Q % growth | 5.07M -63.58% | 6.897M | -1.827M | -26.49% |
| Q1 2021 Q2Q % growth | 5.5M -50.41% | 7.888M | -2.388M | -30.27% |
| Q4 2020 Q2Q % growth | 6.06M -81.32% | 5.667M | 393K | 6.93% |
| Q3 2020 Q2Q % growth | 4.95M -88.59% | 14.313M | -9.363M | -65.42% |
| Q2 2020 Q2Q % growth | 13.92M -55.77% | 10.873M | 3.047M | 28.02% |
| Q1 2020 Q2Q % growth | 11.09M -49.48% | 22.647M | -11.557M | -51.03% |
| Q4 2019 Q2Q % growth | 32.44M | 36.299M | -3.859M | -10.63% |
| Q3 2019 Q2Q % growth | 43.39M | 43.284M | 106K | 0.24% |
| Q2 2019 Q2Q % growth | 31.47M | 27.651M | 3.819M | 13.81% |
| Q1 2019 Q2Q % growth | 21.95M | 20.544M | 1.406M | 6.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 33.33% | 0% | 0% |
| Revenue | 0% | -0.78% | 0% | 0% |